Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04274218 · ClinicalTrials.gov registry record · NA

Upper Limb Loss Perturbation Response

A NA study of Amputation, sponsored by VA Office of Research and Development.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT04274218: Completed NA study of Amputation, sponsored by VA Office of Research and Development.

NCT04274218 is a NA study of Amputation that has completed, run by VA Office of Research and Development. The registered enrollment target is 20 participants, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT04274218, a NA study of Amputation, has completed, sponsored by VA Office of Research and Development.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Recent investigations have suggested that persons with upper limb loss experience a high prevalence of falls with a quarter of reported falls resulting from a trip. Moreover, studies indicate that missing part of an arm may negatively impact balance and that use of a prosthesis exacerbates this problem. While the investigators are beginning to understand the effects of upper limb loss on balance, the understanding of how Veterans with upper limb loss respond to walking disturbances is incomplete. Therefore, the aims of this study are to observe the effects of upper limb loss and wearing a prosthesis on the preparation and recovery of Veterans who trip during walking. The investigators plan to use unique treadmill technology to deliver controlled, yet unexpected, perturbations to Veterans with upper limb loss and non-amputee controls, and assess walking stability through body dynamics. Results from this study will help us understand why Veterans with upper limb loss fall as a critical first step to addressing this problem through balance-targeted interventions that are integrated into patient care.

Primary Outcome

Whole-body angular momentum is the momentum of all limb segments about the Body Center of Mass (BCoM) summed. Whole-body angular momentum is estimated in the sagittal plane, which is the plane of walking progression, and the range of this value is normalized to a person's body mass, height, and walking speed. Whole body angular momentum is minimized by the central nervous system to facilitate postural control. For this study, whole body angular momentum range was averaged across the 12 perturbat

Conditions Studied

Interventions

  • OTHER Perturbation

Study Locations (1)

Illinois

  • Jesse Brown VA Medical Center, Chicago, IL - Chicago

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2020-12-11
Est. Completion 2022-06-30
Phase NA
VA Office of Research and Development

1,668 total trials

What the finished NCT04274218 record still lists

NCT04274218 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 133-participant average among 65 other Amputation trials with a reported enrollment target (85% lower).

The record links to 1 condition, with Amputation appearing as the primary indexed condition, and to 1 intervention - of which Perturbation is the first listed.

NCT04274218 reports a single indexed study location in Illinois.

Frequently Asked Questions

What is clinical trial NCT04274218 about?

NCT04274218 is a clinical study titled "Upper Limb Loss Perturbation Response". Recent investigations have suggested that persons with upper limb loss experience a high prevalence of falls with a quarter of reported falls resulting from a trip. Moreover, studies indicate that missing part of an arm may negatively impact balance and that use of a prosthesis exacerbates this prob...

What is the current status of trial NCT04274218?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2020-12-11. Estimated completion is 2022-06-30.

What conditions does trial NCT04274218 study?

This clinical trial studies the following conditions: Amputation.

What interventions are being tested in trial NCT04274218?

The interventions under investigation include: Perturbation (OTHER).

Who is sponsoring clinical trial NCT04274218?

This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04274218 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Amputation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04274218's enrollment target sits among peer trials

20 33rd of 65 higher than 25 of 65 other Amputation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Amputation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04274218, the US trial registry maintained by the National Library of Medicine. NCT04274218 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.